The authors proposed that the relative risk of conversion to dementia is lower in APOE ε4 carriers, compared to APOE ε3, because progression is likely driven by additional pathological pathways related to the ε4 allele, and unrelated to apathy. The gene discussed is APOE; the disease is Apathy.